Xtant Medical Holdings (XTNT) Total Current Liabilities (2010 - 2025)
Xtant Medical Holdings' (XTNT) quarterly Total Current Liabilities came in at $29.5 million in Q4 2025, up 3.16% year-on-year from $28.6 million in Q4 2024, and down 16.95% on a QoQ basis from $35.5 million in Q3 2025.
Xtant Medical Holdings (XTNT) Total Current Liabilities (2010 - 2025) Analysis & Trends
Xtant Medical Holdings (XTNT) has 16 years of Total Current Liabilities data on file, last reported at $29.5 million in Q4 2025.
- On a quarterly basis, Total Current Liabilities rose 3.16% year-over-year to $29.5 million in Q4 2025; TTM through Dec 2025 was $29.5 million, a 3.16% increase from a year earlier, with the FY2025 full-year figure at $29.5 million, up 3.16% from the prior year.
- Total Current Liabilities for Q4 2025 stood at $29.5 million, down from $35.5 million in the prior quarter.
- Over the last five years, Total Current Liabilities for XTNT reached as high as $35.5 million in Q3 2025 and fell as low as $10.4 million in Q3 2021.
- Historically, Total Current Liabilities has averaged $21.6 million across 5 years, with a median of $22.5 million in 2023.
- On a YoY basis, Total Current Liabilities climbed as much as 138.69% in 2021 and fell as far as 56.81% in 2021.
- Year by year, Total Current Liabilities stood at $11.1 million in 2021, then surged by 37.38% to $15.2 million in 2022, then jumped by 51.07% to $23.0 million in 2023, then increased by 24.32% to $28.6 million in 2024, then advanced by 3.16% to $29.5 million in 2025.
- Per Business Quant data, the three most recent Total Current Liabilities figures were $29.5 million in Q4 2025, $35.5 million in Q3 2025, and $30.6 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 18.38 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 6.32 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 11.66 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 4.57 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 1.41 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 2.22 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 8.70 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 8.53 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 1.60 Bn |
| 10 | Xtant Medical Holdings | 5.69 Mn | -11.63 Mn | 17.75 Mn | 29.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 29.48 Mn |
| Sep 30, 2025 | 35.50 Mn |
| Jun 30, 2025 | 30.60 Mn |
| Mar 31, 2025 | 29.58 Mn |
| Dec 31, 2024 | 28.58 Mn |
| Sep 30, 2024 | 33.67 Mn |
| Jun 30, 2024 | 28.31 Mn |
| Mar 31, 2024 | 28.44 Mn |
| Dec 31, 2023 | 22.99 Mn |
| Sep 30, 2023 | 21.92 Mn |
| Jun 30, 2023 | 16.99 Mn |
| Mar 31, 2023 | 17.28 Mn |
| Dec 31, 2022 | 15.22 Mn |
| Sep 30, 2022 | 11.36 Mn |
| Jun 30, 2022 | 11.86 Mn |
| Mar 31, 2022 | 11.23 Mn |
| Dec 31, 2021 | 11.08 Mn |
| Sep 30, 2021 | 10.40 Mn |
| Jun 30, 2021 | 12.92 Mn |
| Mar 31, 2021 | 24.01 Mn |